Has Jessica Hart, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,675 in general payments to Jessica Hart, MD across 23 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Hart, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Hart, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Hart, MD

Sports Medicine · Great Falls, MTNPI 1790121580

Payments from drug & device makers

What this record shows

This record is dominated by education: $5,629 of the $7,675 with a category attached, or 73.3%. Smith+Nephew accounts for 69.6% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $5,439 and has fallen 98.2% since, to $97 in 2025.

$7,675in general payments, 2019–2025

Across 23 payments — averaging $333.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$5K
Zimmer Biomet$2K
Stryker$144
Johnson & Johnson$132
Vericel Corporation$39
Sioux Surgical Inc$24
plus $15 from 1 others

What the payments were for

Travel & lodging$1,32017%
Food & beverage$7269%
Education$5,62973%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	1	$5,344
Zimmer Biomet	14	$1,978
Stryker	2	$144
Johnson & Johnson	2	$132
Vericel Corporation	2	$39
Sioux Surgical Inc	1	$24
Arthrex	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,675 in reported general payments places this provider in the 85th percentile of 23 sports medicine providers in Montana.

See all sports medicine providers in Montana →

Medicare billing

Part B allowed, 2024

$55,843

Medicare patients

Services billed

215

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	13	$458
Oxycodone Hcl	32	$174

Paid to pharmacies, not to this prescriber.

Other sports medicine in Great Falls

Andrew BlackmanGreat Falls$1K
Patrick ThomasGreat Falls$378
Gregory TierneyGreat Falls$110
Flint RayGreat Falls$109
Phillip SteeleHelena$75K
Brandon BeamerBozeman$72K
Joshua BowlerBillings$25K
Julienne LippeLibby$6K
Mark DeibertBozeman$5K
Noah MarksBillings$3K

See the full list for Montana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →